On Point Scientific provides strategic communications to support product development that ultimately benefits patients.
While much medical writing is proprietary and thus confidential, here are some samples from On Point Scientific that are publicly available.
Monographs and Meeting Reports
- European Lung Cancer Conference
- The Endocrine Society: ENDO
- Highlights in Advanced Prostate Cancer From the 2013 American Society of Clinical Oncology Genitourinary Cancers Symposium
- Recent Advances in Taxanes for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
- Clinical Roundtable Monograph: Emerging Treatments in Chemotherapy-Induced Nausea and Vomiting
- Highlights in the Management of Breast Cancer From the 2012 San Antonio Breast Cancer Symposium (SABCS)
- Highlights in NSCLC From the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology
- Highlights in Lymphoma From the 2012 European Hematology Association Annual Meeting
- Clinical Roundtable Monograph: Recent Advances in Taxanes for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Medical News and Features
- EHA 2016: Stopping TKIs in CML and Improving Overall Survival in ALL
- Memorable Moments: The ASCO 2016 Experience for Physicians
- Hope and Hype: Questions Surround Liquid Biopsies
- Oncologists Become More Vocal About Rising Costs
- New Tools from ASCO and NCCN Address Value
- Cost Challenges in Developing New Oncology Drugs
- Mapping the future for cancer research: TCGA project
- Using genomic testing to steer clinical treatment decisions
- Outlook for Patient Support Philanthropies
- Anemia in Cancer Patients
- Update on the Treatment of Pediatric Ewing Sarcoma
- Long-Term Follow-Up for Late Effects in Survivors of Childhood and Adolescent/Young Adult Cancers
- Emerging Therapies for Ovarian Cancer
- Integration of Palliative Care into Standard Oncology Care
- Translating Genomics into Action in Pediatric Cancer
- Consolidations Come with Concerns as NCI Cooperative Groups Restructure
- How do NCI Cooperative Groups Accomplish So Much with a Budget of about $150M from NCI?
- Putting Patients in the Driver’s Seat for Molecular Diagnostics and Treatments
- New Studies in Lung Cancer Prevention and Detection Reveal Positive Results